Veterinary Oncology Market Size, Trends, Analysis, and Outlook By Therapy (Surgery, Radiotherapy, Chemotherapy, Immunotherapy, Others), By Animal (Canine, Feline, Equine), By Cancer (Skin Cancers, Lymphomas, Sarcomas, Others), by Region, Country, Segment, and Companies, 2024-2030
The global Veterinary Oncology market size is poised to register 10.26% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Veterinary Oncology market across By Therapy (Surgery, Radiotherapy, Chemotherapy, Immunotherapy, Others), By Animal (Canine, Feline, Equine), By Cancer (Skin Cancers, Lymphomas, Sarcomas, Others).
The Veterinary Oncology Market is experiencing growth driven by the increasing prevalence of cancer in companion animals and the demand for comprehensive cancer care services including diagnostics, surgery, chemotherapy, and radiation therapy. Key trends shaping its future include the development of novel cancer therapeutics and targeted therapies tailored to specific tumor types and molecular profiles in dogs, cats, and horses, the expansion of specialty oncology centers offering advanced treatment modalities and supportive care, and the integration of palliative care and pain management strategies to improve quality of life in cancer patients. Additionally, factors such as the aging pet population and the growing awareness of cancer screening and early detection are expected to drive market growth in 2024 and beyond.
Veterinary Oncology Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Veterinary Oncology market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Veterinary Oncology survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Veterinary Oncology industry.
Key market trends defining the global Veterinary Oncology demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Veterinary Oncology Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Veterinary Oncology industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Veterinary Oncology companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Veterinary Oncology industry
Leading Veterinary Oncology companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Veterinary Oncology companies.
Veterinary Oncology Market Study- Strategic Analysis Review
The Veterinary Oncology market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Veterinary Oncology industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Veterinary Oncology Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Veterinary Oncology Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Veterinary Oncology market segments. Similarly, Strong end-user demand is encouraging Canadian Veterinary Oncology companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Veterinary Oncology market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Veterinary Oncology Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Veterinary Oncology industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Veterinary Oncology market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Veterinary Oncology Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Veterinary Oncology in Asia Pacific. In particular, China, India, and South East Asian Veterinary Oncology markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Veterinary Oncology Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Veterinary Oncology Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Veterinary Oncology market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Veterinary Oncology.
Veterinary Oncology Market Company Profiles
The global Veterinary Oncology market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Accuray Inc, Boehringer Ingelheim GmbH, Elanco, Karyopharm Therapeutics Inc, One Health, PetCure Oncology, Regeneus Ltd, Varian Medical Systems, Zoetis
Recent Veterinary Oncology Market Developments
The global Veterinary Oncology market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Veterinary Oncology Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Therapy
Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Others
By Animal
Canine
Feline
Equine
By Cancer
Skin Cancers
Lymphomas
Sarcomas
Others
Geographical Segmentation:
Accuray Inc
Boehringer Ingelheim GmbH
Elanco
Karyopharm Therapeutics Inc
One Health
PetCure Oncology
Regeneus Ltd
Varian Medical Systems
Zoetis
Formats Available: Excel, PDF, and PPT
The Veterinary Oncology Market is experiencing growth driven by the increasing prevalence of cancer in companion animals and the demand for comprehensive cancer care services including diagnostics, surgery, chemotherapy, and radiation therapy. Key trends shaping its future include the development of novel cancer therapeutics and targeted therapies tailored to specific tumor types and molecular profiles in dogs, cats, and horses, the expansion of specialty oncology centers offering advanced treatment modalities and supportive care, and the integration of palliative care and pain management strategies to improve quality of life in cancer patients. Additionally, factors such as the aging pet population and the growing awareness of cancer screening and early detection are expected to drive market growth in 2024 and beyond.
Veterinary Oncology Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Veterinary Oncology market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Veterinary Oncology survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Veterinary Oncology industry.
Key market trends defining the global Veterinary Oncology demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Veterinary Oncology Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Veterinary Oncology industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Veterinary Oncology companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Veterinary Oncology industry
Leading Veterinary Oncology companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Veterinary Oncology companies.
Veterinary Oncology Market Study- Strategic Analysis Review
The Veterinary Oncology market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Veterinary Oncology industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Veterinary Oncology Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Veterinary Oncology Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Veterinary Oncology market segments. Similarly, Strong end-user demand is encouraging Canadian Veterinary Oncology companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Veterinary Oncology market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Veterinary Oncology Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Veterinary Oncology industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Veterinary Oncology market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Veterinary Oncology Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Veterinary Oncology in Asia Pacific. In particular, China, India, and South East Asian Veterinary Oncology markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Veterinary Oncology Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Veterinary Oncology Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Veterinary Oncology market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Veterinary Oncology.
Veterinary Oncology Market Company Profiles
The global Veterinary Oncology market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Accuray Inc, Boehringer Ingelheim GmbH, Elanco, Karyopharm Therapeutics Inc, One Health, PetCure Oncology, Regeneus Ltd, Varian Medical Systems, Zoetis
Recent Veterinary Oncology Market Developments
The global Veterinary Oncology market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Veterinary Oncology Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Therapy
Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Others
By Animal
Canine
Feline
Equine
By Cancer
Skin Cancers
Lymphomas
Sarcomas
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Accuray Inc
Boehringer Ingelheim GmbH
Elanco
Karyopharm Therapeutics Inc
One Health
PetCure Oncology
Regeneus Ltd
Varian Medical Systems
Zoetis
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Veterinary Oncology Market Overview and Key Findings, 2024
1.2 Veterinary Oncology Market Size and Growth Outlook, 2021- 2030
1.3 Veterinary Oncology Market Growth Opportunities to 2030
1.4 Key Veterinary Oncology Market Trends and Challenges
1.4.1 Veterinary Oncology Market Drivers and Trends
1.4.2 Veterinary Oncology Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Veterinary Oncology Companies
2. VETERINARY ONCOLOGY MARKET SIZE OUTLOOK TO 2030
2.1 Veterinary Oncology Market Size Outlook, USD Million, 2021- 2030
2.2 Veterinary Oncology Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. VETERINARY ONCOLOGY MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. VETERINARY ONCOLOGY MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Therapy
Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Others
By Animal
Canine
Feline
Equine
By Cancer
Skin Cancers
Lymphomas
Sarcomas
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Veterinary Oncology Market, 2025
5.2 Asia Pacific Veterinary Oncology Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Veterinary Oncology Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Veterinary Oncology Market, 2025
5.5 Europe Veterinary Oncology Market Size Outlook by Type, 2021- 2030
5.6 Europe Veterinary Oncology Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Veterinary Oncology Market, 2025
5.8 North America Veterinary Oncology Market Size Outlook by Type, 2021- 2030
5.9 North America Veterinary Oncology Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Veterinary Oncology Market, 2025
5.11 South America Pacific Veterinary Oncology Market Size Outlook by Type, 2021- 2030
5.12 South America Veterinary Oncology Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Veterinary Oncology Market, 2025
5.14 Middle East Africa Veterinary Oncology Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Veterinary Oncology Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Veterinary Oncology Market Size Outlook and Revenue Growth Forecasts
6.2 US Veterinary Oncology Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Veterinary Oncology Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Veterinary Oncology Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Veterinary Oncology Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Veterinary Oncology Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Veterinary Oncology Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Veterinary Oncology Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Veterinary Oncology Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Veterinary Oncology Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Veterinary Oncology Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Veterinary Oncology Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Veterinary Oncology Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Veterinary Oncology Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Veterinary Oncology Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Veterinary Oncology Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Veterinary Oncology Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Veterinary Oncology Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Veterinary Oncology Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Veterinary Oncology Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Veterinary Oncology Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Veterinary Oncology Industry Drivers and Opportunities
7. VETERINARY ONCOLOGY MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. VETERINARY ONCOLOGY COMPANY PROFILES
8.1 Profiles of Leading Veterinary Oncology Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Accuray Inc
Boehringer Ingelheim GmbH
Elanco
Karyopharm Therapeutics Inc
One Health
PetCure Oncology
Regeneus Ltd
Varian Medical Systems
Zoetis
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Veterinary Oncology Market Overview and Key Findings, 2024
1.2 Veterinary Oncology Market Size and Growth Outlook, 2021- 2030
1.3 Veterinary Oncology Market Growth Opportunities to 2030
1.4 Key Veterinary Oncology Market Trends and Challenges
1.4.1 Veterinary Oncology Market Drivers and Trends
1.4.2 Veterinary Oncology Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Veterinary Oncology Companies
2. VETERINARY ONCOLOGY MARKET SIZE OUTLOOK TO 2030
2.1 Veterinary Oncology Market Size Outlook, USD Million, 2021- 2030
2.2 Veterinary Oncology Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. VETERINARY ONCOLOGY MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. VETERINARY ONCOLOGY MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Therapy
Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Others
By Animal
Canine
Feline
Equine
By Cancer
Skin Cancers
Lymphomas
Sarcomas
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Veterinary Oncology Market, 2025
5.2 Asia Pacific Veterinary Oncology Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Veterinary Oncology Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Veterinary Oncology Market, 2025
5.5 Europe Veterinary Oncology Market Size Outlook by Type, 2021- 2030
5.6 Europe Veterinary Oncology Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Veterinary Oncology Market, 2025
5.8 North America Veterinary Oncology Market Size Outlook by Type, 2021- 2030
5.9 North America Veterinary Oncology Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Veterinary Oncology Market, 2025
5.11 South America Pacific Veterinary Oncology Market Size Outlook by Type, 2021- 2030
5.12 South America Veterinary Oncology Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Veterinary Oncology Market, 2025
5.14 Middle East Africa Veterinary Oncology Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Veterinary Oncology Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Veterinary Oncology Market Size Outlook and Revenue Growth Forecasts
6.2 US Veterinary Oncology Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Veterinary Oncology Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Veterinary Oncology Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Veterinary Oncology Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Veterinary Oncology Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Veterinary Oncology Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Veterinary Oncology Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Veterinary Oncology Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Veterinary Oncology Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Veterinary Oncology Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Veterinary Oncology Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Veterinary Oncology Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Veterinary Oncology Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Veterinary Oncology Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Veterinary Oncology Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Veterinary Oncology Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Veterinary Oncology Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Veterinary Oncology Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Veterinary Oncology Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Veterinary Oncology Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Veterinary Oncology Industry Drivers and Opportunities
7. VETERINARY ONCOLOGY MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. VETERINARY ONCOLOGY COMPANY PROFILES
8.1 Profiles of Leading Veterinary Oncology Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Accuray Inc
Boehringer Ingelheim GmbH
Elanco
Karyopharm Therapeutics Inc
One Health
PetCure Oncology
Regeneus Ltd
Varian Medical Systems
Zoetis
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
